共 50 条
B cells for cancer immunotherapy
被引:6
|作者:
Deng, Jiusheng
[1
]
Galipeau, Jacques
[1
,2
]
机构:
[1] Emory Univ, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA 30322 USA
[2] Emory Univ, Dept Pediat, Winship Canc Inst, Atlanta, GA 30322 USA
关键词:
B cells;
cancer immunotherapy;
fusion cytokine;
GIFT4;
ANTITUMOR IMMUNITY;
D O I:
10.4161/21624011.2014.955702
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
We have engineered a novel fusion cytokine named GIFT4 derived from GM-CSF and IL-4, and displaying robust gain-of-function immunostimulatory effects on B cells. GIFT4-programmed B cells have a unique identity and potent capacity to elicit a tumoricidal - cell response, thus comprising a novel B cell-based cancer immunotherapeutic approach.
引用
收藏
页码:e955702 / 1
页数:3
相关论文